Floatz logo

373 assets in Non-Hodgkin Lymphoma

Therapeutic assets addressing Non-Hodgkin Lymphoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Autologous Car19 T Lymphocytes
Non-Hodgkin Lymphoma
Institute of Hematology and Blood Transfusion, Czech RepublicP1CC (43)
Autologous Cd19Car-Cd28-Cd3Zeta-Egfrt-Expressing Tcm-Enriched T Cells
Non-Hodgkin Lymphoma
City of Hope Medical CenterP1CC (43)
Autologous Cd19Car-Cd28-Cd3Zeta-Egfrt-Expressing Tn/Mem-Enriched T-Lymphocytes
Non-Hodgkin Lymphoma
City of Hope Medical CenterP1CC (43)
azd3470
Non-Hodgkin Lymphoma
AstraZenecaP1/2CC (43)
Bgb-16673
Non-Hodgkin Lymphoma
BeiGeneP1/2CC (43)
Bgb-21447
Non-Hodgkin Lymphoma
BeOne MedicinesP1CC (43)
Bitr2101
Non-Hodgkin Lymphoma
Boston Immune Technologies and TherapeuticsP1CC (43)
bn301
Non-Hodgkin Lymphoma
BioNova Pharmaceuticals (Shanghai) LTD.P1/2CC (43)
Cart-19 And 20 Cells
Non-Hodgkin Lymphoma
University of Sao PauloP1/2CC (43)
Cart30
Non-Hodgkin Lymphoma
Chinese PLA General HospitalP1/2CC (43)
CD19.CAR-aNKT cells
Non-Hodgkin Lymphoma
Baylor College of MedicineP1CC (43)
cd19 t-hank
Non-Hodgkin Lymphoma
ImmunityBio, Inc.P1CC (43)
Cemsidomide
Non-Hodgkin Lymphoma
C4 Therapeutics, Inc.P1CC (43)
cht101
Non-Hodgkin Lymphoma
Tianjin Medical University Cancer Institute and HospitalP1CC (43)
Clic-1901
Non-Hodgkin Lymphoma
Ottawa Hospital Research InstituteP1/2CC (43)
Cln-978
Non-Hodgkin Lymphoma
Cullinan Therapeutics Inc.P1CC (43)
Cnty-101
Non-Hodgkin Lymphoma
Century Therapeutics, Inc.P1CC (43)
ctx112
Non-Hodgkin Lymphoma
CRISPR Therapeutics AGP1/2CC (43)
Cytokine-Treated Veto Cells
Non-Hodgkin Lymphoma
M.D. Anderson Cancer CenterP1/2CC (43)
Elranatamab
Non-Hodgkin Lymphoma
CellCentric Ltd.P1/2CC (43)
Englumafusp Alfa
Non-Hodgkin Lymphoma
Hoffmann-La RocheP1/2CC (43)
Eth-155008
Non-Hodgkin Lymphoma
Shengke Pharmaceuticals (Jiangsu) Limited, ChinaP1CC (43)
fd-001
Non-Hodgkin Lymphoma
Chengdu FenDi Pharmaceutical Co., Ltd.P1CC (43)
gen1160
Non-Hodgkin Lymphoma
GenmabP1/2CC (43)
gen3017
Non-Hodgkin Lymphoma
GenmabP1/2CC (43)
Glyco-Engineered Anti-Cd20 Monoclonal Antibody Cho H01
Non-Hodgkin Lymphoma
Cho Pharma Inc.P1/2CC (43)
Gnc-035
Non-Hodgkin Lymphoma
Sichuan Baili Pharmaceutical Co., Ltd.P1/2CC (43)
hcb101
Non-Hodgkin Lymphoma
FBD Biologics LimitedP1CC (43)
Hmpl-760
Non-Hodgkin Lymphoma
HutchmedP1CC (43)
Hpc-A
Non-Hodgkin Lymphoma
St. Jude Children's Research HospitalP2CC (43)
hsk47977
Non-Hodgkin Lymphoma
Haisco Pharmaceutical Group Co., Ltd.P1CC (43)
hy004
Non-Hodgkin Lymphoma
Juventas Cell Therapy Ltd.P1/2CC (43)
Inobrodib
Non-Hodgkin Lymphoma
CellCentric Ltd.P1/2CC (43)
iph6501
Non-Hodgkin Lymphoma
Innate PharmaP1/2CC (43)
JL19001
Non-Hodgkin Lymphoma
Jecho Biopharmaceuticals Co., Ltd.P1CC (43)
Kur-502
Non-Hodgkin Lymphoma
Athenex, Inc.P1CC (43)
Lentivirus Vector Rhiv7-Shi-Tar-Ccr5Rz-Transduced Hematopoietic Stem/Progenitor Cells
Non-Hodgkin Lymphoma
City of Hope Medical CenterP1CC (43)
ly4584180
Non-Hodgkin Lymphoma
Eli Lilly and CompanyP1CC (43)
mbs303
Non-Hodgkin Lymphoma
Beijing Mabworks Biotech Co., Ltd.P1/2CC (43)
mk-1045
Non-Hodgkin Lymphoma
Merck Sharp & Dohme LLCP1/2CC (43)
n803
Non-Hodgkin Lymphoma
ImmunityBio, Inc.P1CC (43)
Neldaleucel
Non-Hodgkin Lymphoma
Marker Therapeutics, Inc.P1CC (43)
Orelabrutinib
Non-Hodgkin Lymphoma
Huiqiang HuangP1/2CC (43)
Parsaclisib
Non-Hodgkin Lymphoma
Incyte CorporationP1/2CC (43)
Pevonedistat
Non-Hodgkin Lymphoma
City of Hope Medical CenterP1CC (43)
Poseltinib
Non-Hodgkin Lymphoma
NOBO MedicineP1CC (43)
Prizloncabtagene Autoleucel
Non-Hodgkin Lymphoma
Janssen Research & Development, LLCP1/2CC (43)
Recombinant Human Hyaluronidase
Non-Hodgkin Lymphoma
Thomas Jefferson UniversityP1CC (43)
Roginolisib
Non-Hodgkin Lymphoma
iOncturaP1CC (43)
sc262
Non-Hodgkin Lymphoma
Sana BiotechnologyP1CC (43)
Showing 201 to 250 of 373 assets
PreviousPage 5 of 8Next